{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T10:40:22Z","timestamp":1782124822343,"version":"3.54.5"},"reference-count":34,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"vor","delay-in-days":316,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015666","name":"Aksum University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015666","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BioMed Research International"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:p><jats:italic>Background<\/jats:italic>. Drug use evaluation is a systematic approach to determining the appropriateness of drug use, identifying drug therapy problems, and proposing interventions. Ceftriaxone is one of the most widely used drugs in hospitals, requiring the performance of drug use evaluation. This study was aimed at evaluating the appropriateness of ceftriaxone use at Kahsay Abera and Mearg hospitals in the Western zone of Tigray, Ethiopia. <jats:italic>Methods<\/jats:italic>. An institution\u2010based retrospective cross\u2010sectional study design was conducted in both hospitals from December 2015 to August 2016 using standardized and pretested data collection formats. Systematic random sampling was used, and a total of 800 patients\u2019 medication records (patients who took ceftriaxone) from both hospitals (400 each) were assessed in this study. Statistical analysis was performed by using the statistical package for social sciences (version 20). <jats:italic>Results<\/jats:italic>. The overall appropriateness of ceftriaxone use in Kahsay Abera and Mearg hospitals was 247 (61.75%) and 252 (63.0%), respectively. The majority of inappropriate use of ceftriaxone was noted in indication errors at both Kahsay Abera (71.2%) and Mearg hospitals (52.0%). The treatment duration in Kahsay Abera (69%) and Mearg hospitals (88%) was in the range of 2\u20107 days. Mostly, a 2\u2010gram ceftriaxone daily dose was prescribed in both Kahsay Abera and Mearg hospitals, accounting for 285 (71.25%) and 318 (79.5%), respectively. In this study, the top three diseases, indicated for ceftriaxone in both hospitals, were typhoid fever, urinary tract infection, and pneumonia in descending order. Among the medications coadministered with ceftriaxone, the top three coprescribed drugs with ceftriaxone in Kahsay Abera Hospital were metronidazole (17.25%), tramadol 68 (11.28%), and diclofenac (8.96%), but in Mearg Hospital, next to metronidazole, drugs like paracetamol and doxycycline were the most common coprescribed medicines along with ceftriaxone. <jats:italic>Conclusion<\/jats:italic>. The appropriateness of ceftriaxone use in Kahsay Abera and Mearg hospitals was 247 (61.8%) and 252 (63%), respectively, in which about one\u2010third of patients\u2019 charts were not compliant with the standard treatment guidelines of Ethiopia for general hospitals. In Kahsay Abera and Mearg hospitals, the empiric use of ceftriaxone was 262 (65.5%) and 375 (93.8%), respectively.<\/jats:p>","DOI":"10.1155\/2023\/7688896","type":"journal-article","created":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T21:20:06Z","timestamp":1699910406000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Ceftriaxone Use Evaluation in Western Zone Tigray Hospitals, Ethiopia: A Retrospective Cross\u2010Sectional Study"],"prefix":"10.1155","volume":"2023","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1296-091X","authenticated-orcid":false,"given":"Tewodros","family":"Shegute","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mulugeta","family":"Hiruy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haftom","family":"Hadush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7544-8430","authenticated-orcid":false,"given":"Leake","family":"Gebremeskel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,11,13]]},"reference":[{"key":"e_1_2_15_1_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.317.7159.647"},{"key":"e_1_2_15_2_2","doi-asserted-by":"publisher","DOI":"10.20529\/IJME.2004.005"},{"key":"e_1_2_15_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit710"},{"key":"e_1_2_15_4_2","first-page":"171","article-title":"Assessment of reasonable use of ceftriaxone in internal and surgical wards","volume":"2010","author":"Shohrati M.","year":"2010","journal-title":"Trauma Monthly"},{"key":"e_1_2_15_5_2","first-page":"265","article-title":"Bacterial evolution and the cost of antibiotic resistance","volume":"1","author":"Lenski R. E.","year":"1998","journal-title":"International Microbiology"},{"key":"e_1_2_15_6_2","doi-asserted-by":"publisher","DOI":"10.1177\/106002808702101216"},{"key":"e_1_2_15_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.2.185"},{"key":"e_1_2_15_8_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4087-z"},{"key":"e_1_2_15_9_2","volume-title":"Goodman and Gilman\u2019s the Pharmacological Basis of Therapeutics","author":"Chabner B. A.","year":"2011"},{"key":"e_1_2_15_10_2","first-page":"1052","article-title":"Evaluation of antibiotic use in medical ward of Fitche District Hospital, north Showa zone, Oromia region, Ethiopia","volume":"6","author":"Gube A.","year":"2017","journal-title":"Advances in Pharmacoepidemiology and Drug Safety"},{"key":"e_1_2_15_11_2","unstructured":"Drug Administration and Control Authority of Ethiopia (DACA) Ethiopian National Drug Formulary 2008 201\u2013202."},{"key":"e_1_2_15_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041359"},{"key":"e_1_2_15_13_2","doi-asserted-by":"publisher","DOI":"10.4065\/74.2.187"},{"key":"e_1_2_15_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-03356-2_6"},{"key":"e_1_2_15_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-6553(97)90054-7"},{"key":"e_1_2_15_16_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365549709035904"},{"key":"e_1_2_15_17_2","doi-asserted-by":"publisher","DOI":"10.1086\/647549"},{"key":"e_1_2_15_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(02)00272-8"},{"key":"e_1_2_15_19_2","volume-title":"Standard Treatment Guidelines for Primary Hospital","author":"Food, Medicine and Healthcare Administration and Control Authority of Ethiopia (FMHACA)","year":"2014"},{"key":"e_1_2_15_20_2","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.70.9.793"},{"key":"e_1_2_15_21_2","volume-title":"Guidelines for Implementing Drug Utilization Review Programs in Hospitals","author":"Moore T.","year":"1997"},{"key":"e_1_2_15_22_2","volume-title":"Department of Essential Drugs and Medicines Policy","author":"Holloway K.","year":"2003"},{"key":"e_1_2_15_23_2","volume-title":"Submitted to the U.S. Agency for International Development by the Rational Pharmaceutical Management Plus Program","author":"Management Sciences for Health and World Health Organization","year":"2007"},{"key":"e_1_2_15_24_2","volume-title":"Standard Treatment Guidelines for General Hospital","author":"Eyasu M.","year":"2014"},{"key":"e_1_2_15_25_2","unstructured":"Drugs.com May 2021 https:\/\/www.drugs.com\/drug_interactions.html."},{"key":"e_1_2_15_26_2","doi-asserted-by":"publisher","DOI":"10.5455\/2319-2003.ijbcp20131208"},{"key":"e_1_2_15_27_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-016-0057-x"},{"key":"e_1_2_15_28_2","article-title":"Drug use evaluation of ceftriaxone: the case of Ayder Referral Hospital, Mekelle, Ethiopia","volume":"3","author":"Abebe F. A.","year":"2012","journal-title":"International Journal of Pharmaceutical Sciences and Research"},{"key":"e_1_2_15_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.383"},{"key":"e_1_2_15_30_2","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2009.24.4.374"},{"key":"e_1_2_15_31_2","doi-asserted-by":"publisher","DOI":"10.25141\/2471-6782-2017-2.0026"},{"key":"e_1_2_15_32_2","doi-asserted-by":"publisher","DOI":"10.2147\/DHPS.S260364"},{"key":"e_1_2_15_33_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40545-015-0047-1"},{"key":"e_1_2_15_34_2","doi-asserted-by":"publisher","DOI":"10.4314\/tjpr.v15i10.29"}],"container-title":["BioMed Research International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/bmri\/2023\/7688896.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/bmri\/2023\/7688896.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/2023\/7688896","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T23:27:23Z","timestamp":1722900443000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/2023\/7688896"}},"subtitle":[],"editor":[{"given":"Francesca","family":"Mancianti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.1155\/2023\/7688896"],"URL":"https:\/\/doi.org\/10.1155\/2023\/7688896","archive":["Portico"],"relation":{},"ISSN":["2314-6133","2314-6141"],"issn-type":[{"value":"2314-6133","type":"print"},{"value":"2314-6141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"2023-04-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"7688896"}}